Our firm represented Claroty in this significant financing round and transaction.
Our firm represented Cardiovalve in this transaction.
Our firm represented the global investment banks that coordinated Bank Hapoalim’s $1 billion global private placement.
We wish to inform you of a new ruling on the liability standard of dual-listed companies and their officials towards […]
Our firm represented Thoma Bravo Advantage (a SPAC) in this transaction.
Our firm represented Shufersal in its innovative 700 million ILS global share offering, the first time in Israel in which […]
We expect that this landmark verdict will serve as a veritable textbook for the conduct of future going private transactions […]
Our firm represented Collective Growth Corporation in this transaction.
The past year has seen significant advances for Israel’s dual-listing arrangement on multiple fronts – legislative, regulatory, judicial and in […]
Our firm represented Nestle in this significant transaction.
An second article by Adv. Adam Klein, Deputy Department Head of the International Corporate and Securities Department, and Adv. Ido […]
An article by Adv. Adam Klein and Adv. Ido Zemach, on Stockholder Rights Plans, or “poison pill”.
